2023
DOI: 10.1080/10408398.2023.2204375
|View full text |Cite
|
Sign up to set email alerts
|

Plant-derived nanoparticles and plant virus nanoparticles: Bioactivity, health management, and delivery potential

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 140 publications
0
3
0
Order By: Relevance
“…Increasing evidence reveals that oral administration of edible plants-derived exosome-like nanoparticles show high stability in the digestive system and potent preventive effects against intestinal disease . Here, we found that oral BENs at a dosage of 17.5 mg/kg·d, passing through the upper digestive tract and entering the colonic sites, suppressed LOP-induced constipation phenotypes including shortened defecation time, accelerated intestinal ink propulsion rate, and increased the amount of feces (Figures and ).…”
Section: Discussionmentioning
confidence: 54%
See 1 more Smart Citation
“…Increasing evidence reveals that oral administration of edible plants-derived exosome-like nanoparticles show high stability in the digestive system and potent preventive effects against intestinal disease . Here, we found that oral BENs at a dosage of 17.5 mg/kg·d, passing through the upper digestive tract and entering the colonic sites, suppressed LOP-induced constipation phenotypes including shortened defecation time, accelerated intestinal ink propulsion rate, and increased the amount of feces (Figures and ).…”
Section: Discussionmentioning
confidence: 54%
“…Increasing evidence reveals that oral administration of edible plants-derived exosome-like nanoparticles show high stability in the digestive system and potent preventive effects against intestinal disease. 28 Here, we found that oral BENs at a dosage of 17.5 mg/kg•d, passing through the upper digestive tract and entering the colonic sites, suppressed LOP-induced constipation phenotypes including shortened defecation time, accelerated intestinal ink propulsion rate, and increased the amount of feces (Figures 2 and 3). At the same time, BENs regulated the production of gastric regulatory peptides in LOP-induced constipated mice, with increased levels of excitatory peptides (SP and MTL) and decreased levels of inhibitory peptides (VIP and ET-1) in the serum and the colon.…”
Section: Discussionmentioning
confidence: 70%
“…In addition, nanotechnology-based drug delivery systems have emerged as an attractive strategy. Compared to MEVs and synthetic nanoparticles, PELNs are non-toxic properties, low immunogenicity, high bioavailability, and easy absorption, which helps to solve the poor bioavailability of many active ingredients ( 31 ). Although these superior characteristics of PELNs have been reviewed in previous publications ( 11 , 20 , 22 , 25 , 32 ), there are still many issues for researchers to refine and investigate.…”
Section: Introductionmentioning
confidence: 99%